pSS patients show an increase in Th17 cells and their characteristic cytokine IL-17, which triggers tissue injury and stimulates responses from autoreactive B cells (Pontarini et al., 2018; Verstappen et al., 2018). The gene discussed is IL17A; the disease is peeling skin syndrome.